We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Roux-en-Y Gastric Bypass Versus Laparoscopic Adjustable Gastric Band Operations on Resistin, Apelin and Visfatin Peptides

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01613391
First Posted: June 7, 2012
Last Update Posted: June 11, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Muhammet Ferhat CELİK, Istanbul University
  Purpose
This study aimed to measure, compare apelin, resistin, visfatin levels in patients underwent to RYGBP, LAGB and their relation with obesity.

Condition
Morbid Obesity

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Effect of Roux-en-Y Gastric Bypass Versus Laparoscopic Adjustable Gastric Band Operations on Resistin, Apelin and Visfatin Peptides

Further study details as provided by Muhammet Ferhat CELİK, Istanbul University:

Enrollment: 30
Study Start Date: July 2011
Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
RYGBP
Patients underwent Roux-en-Y Gastric Bypass for morbid obesity.
LAGB
Patients underwent Laparoscopic Adjustable Gastric Banding for morbid obesity.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Morbidly obese 15 patients underwent LAGB and 15 patients underwent RYGBP
Criteria

Inclusion Criteria:

  • Clinical diagnosis of morbid obesity
  • Being underwent LAGB or RYGBP

Exclusion Criteria:

  • Having prior abdominal surgery history
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01613391


Locations
Turkey
Istanbul University Cerrahpasa Medical Faculty
Istanbul, Turkey, 34098
Sponsors and Collaborators
Istanbul University
  More Information

Responsible Party: Muhammet Ferhat CELİK, Medical Doctor, Istanbul University
ClinicalTrials.gov Identifier: NCT01613391     History of Changes
Other Study ID Numbers: IU-BS-2012-RAV
First Submitted: June 5, 2012
First Posted: June 7, 2012
Last Update Posted: June 11, 2012
Last Verified: June 2012

Keywords provided by Muhammet Ferhat CELİK, Istanbul University:
Visfatin
Resistin
Apelin
roux-en-y gastric bypass
laparoscopic adjustable gastric banding
morbid obesity

Additional relevant MeSH terms:
Obesity, Morbid
Obesity
Overnutrition
Nutrition Disorders
Overweight
Body Weight
Signs and Symptoms